Society for Laboratory Automation & Screening Ignite Award

Tango Biosciences was nominated as a finalist for the best start-up or emerging company. Named “one of the top 8 bioscience start-ups in 2019.”

More News and Events

Event

SLAS 2025

Visit Tango Biosciences at the 2025 SLAS International Conference & Exhibition! January 25-29, 2025 | San Diego, CA Booth #2317 Plus, mark your calendar to join our Solution Spotlight presentation: Rapid Phage Display Solutions ideal for SLAS: Screening Ligands for Affinity and Selectivity Tuesday, January 28 | 5:00 PM – 5:20 PM PST
News

NIH SBIR Award

The National Institutes of Health (NIH) awarded a phase I grant to Tango Biosciences in January 2021. This award will support a collaborative effort that generates recombinant antibodies and antibody-like reagents for 6 SARS-CoV-2 viral proteins. These reagents will aid scientists in understanding the function of these viral proteins inside infected cells. Such information may […]
News

Tango Biosciences publishes work on SARS-CoV-2 virus

Tango Biosciences scientists, in collaboration with colleagues from B2S Life Sciences, LifeTein, and Euprotein, publish a scientific report on generating recombinant affinity reagents (monobodies) to the receptor binding domain (RBD) of the SARS-CoV-2 virus, which is responsible for the COVID-19 pandemic. Soluble forms of the monobodies bound to several different preparations of the RBD and […]